Clinical Chemistry

Article	Citations
Commentary on A Differential Diagnosis of Thrombotic Microangiopathy in a 7-Year-Old Girl	218
Commentary on Understanding Elevated Vitamin D Measurements to Uncover Hypercalcemia Etiology	213
Correction to: Driving Under the Influence of Cannabis: Impact of Combining Toxicology Testing with Field Sobriety Tests	129
Clinical Chemistry's Invited Reviewers 2024	106
B-314 Utility of he4 in differential diagnosis of pleural effusions	88
A-125 Difference Between the Results of Vitros® Dry Biochemistry and Wet Biochemistry with Kinetic Method in Diagnosing the Comorbidity of Lung Adenocarcinoma and Aacroamylasemia: Case Report	81
A-194 Intravenous Fluid Contamination of Basic Metabolic Panels Is Underrecognized by Manual Workflows	74
A-249 Theranostic Algorithm: sensitivity and Specificity of a Composite Index Test for Guiding Treatment in Severe COVID-19	72
B-048 Proposal of a new monitoring algorythm for patients with a HIV positive result with the Elecsys HIV DUO test	68
B-080 Analytical Performance of ESPLINE HTLV-I/II	64
A-390 Implementation of the New GEM Hemochron 100 Point-of-care Coagulation System for Heparin Monitoring During Cardiopulmonary Bypass Procedures	63
B-276 Preservation of Proteomic Inflammatory Biomarkers signal in a Saliva Multiomic Buffer at Room Temperature	56
B-090 Evaluation of Clinical Serology Assays Through the Development of Linearity Materials for aHBs IgG, Rubella IgG, and Toxoplasma IgG	53
B-102 The Impact of Protein / Protein Interactions on Serum Free Light Chain Assay Calibration	53
B-097 Storage Stability of HbA1c in Whole Blood Tubes at Room Temperature on the Abbott Alinity c Clinical Chemistry System	52
A-143 Comparative Evaluation of K2EDTA Performance in Multinational Vacutainers: A Case Study of “DBO” by Schraubg and “BD” by Becton, Dickinson	48
B-305 A Novel Dilute-n-shoot Method for Quantitating Isotonitazene and Desmetonitazene in Human Urine By LC/MS	48
B-247 Rapid and Field-deployable Microchip-based Real-time PCR for Hepatitis B Virus DNA Detection	45
A-173 Evaluation of Artificial Intelligence (AI)-assisted Flow Cytometry Analysis for Plasma Cell Neoplasms	44
A-101 Is That Unexpected? Education on Handling Real World Complications with Tightly Controlled Analytes During Method Evaluation	44
A-377 The Selection and Implementation of POC Illicit Drug Toxicology Testing in Hamad Medical Corporation - Doha, Qatar	42
B-253 Using biomarkers in recurrent renal stone formers to detect silent stones	42
B-208 Room Temperature Stable PCR Reagents Preparation Using Capillary-Mediated Vitrification Process	41
A-023 Performance Evaluation of the Atellica IM High-Sensitivity Troponin I Assay on the Atellica CI 1900 Analyzer	39
B-011 Analytical Validation of a New Vasoactive Intestinal Peptide Radioimmunoassay	38

A-339 Utomated Flow of a Non-invasive Fetal Gender Determination Lab-developed Molecular Test	37
B-110 Validation of Digital and Automated anti-dsDNA IFA Interpretations Using the dIFine Automated Fluorescent Microscope System	37
B-092 Effect of the Increased Specificity in a Recombinant anti-tTG Assay on a Celiac Disease Diagnostic Algorithm	36
B-067 Human IgE Monoclonal Antibodies as Unique Tools for Allergy Diagnostics	36
A-117 Performance Evaluation of five Sentinel Diagnostics’ Assays on Beckman Coulter DxC 500 AU Clinical Chemistry Analyzer	35
A-292 The Use of Third-Party Controls During Covid-19 Pandemic: An Alternative to the Lack of Other Respiratory Infections	32
A-142 Comparison of Alinity c Hemoglobin A1c Immunoassay with Premier Hb9210 Automated HPLC Assay: Very Few Patients May be Outside Reportable Range Using Alinity c.	31
A-154 Reduction in Turnaround Time Achieved by Simplifying Hematology Middleware Rules	31
A-170 CBC Results, flags and scattergram using BC 6800Plus Hematology Analyzer, for a case of Burkitt*s lymphoma in leukemic phase	30
A-213 Highlights on Daily Internal Quality Controls for Improved Analytical Performance in Clinical Laboratory	30
A-032 Evaluation of the Analytical Performance of Total Triiodothyronine (T3) and Total Thyroxine (T4) Assays on the Atellica CI Analyzer	28
A-268 Evaluation of NAAT Recovery of Highly Pathogenic Avian Influenza A (H5N1) Clade 2.3.4.4b from Novel Proficiency Samples	28
B-088 Stability Assessment of Hormones and Tumor Markers: Can We Ensure High-Quality Patient Results Despite Operational Challenges?	27
B-043 Clinical performance evaluation of the ABD PAD® as confirmatory testing of blood group	27
A-291 Rapidly Ruling Out Bacterial Infection: A Novel Host-Protein Assay for Patients with Suspected Respiratory Tract Infections in the Emergency Department	27
B-277 Validation of an Enzymatic Method for Quantification of Ethylene Glycol in Human Serum	27
B-007 Activin A is a potential mediator of TGFß1-induced tubulointerstitial fibrosis	27
A-181 Stability of urine in the BD Vacutainer® Plus Conical Urinalysis Preservative Tubes for Chemical and Microscopic Urinalysis	27
B-214 Migration of a Previously Validated Sequencing Workflow of 4,700 Genes Associated with Clinical Phenotypes to the MGI DNBSEQ-G400 Platform: High-Quality NGS Data with Elevated Concordance to Exp	27
A-312 Evaluation of the Analytical Performance of the Hepatitis B Surface Antigen and confirmatory assays on the Atellica CI Analyzer	27
A-172 Graphical contribution and CBC of BC-6800Plus hematology analyzer in a case of Myelodisplastic Syndrome related to Chemotherapy and Radiotherapy	27
B-117 Inverse Association Between Regulatory T and B Cells with HLA antibodies and Donor-specific Antibodies in Kidney Transplantation	26
A-050 The Role of Gut Microbial Metabolite Trimethylamine N-Oxide in Adrenal Cholesterol Homeostasis	26
B-255 Engineered Reverse Transcriptases and Taq DNA Polymerases Deliver Robust Yield in the Presence of Clinically Relevant Inhibitors	26
B-278 Xylazine Detection in Clinical Urine Specimens Ordered for Comprehensive Drug Screening	26
A-034 Prevention of Obesity and Metabolic Disorders Through a Gut Microbial Metabolite Derived from Polyphenol Supplementation in a High-Fat Diet	26
B-182 Evaluating Clinical Biochemical Diagnostic Approaches for Mitochondrial Diseases	26
A-072 The Impact of Short and Prolonged Fasting on Routine Lab Tests	26
Cerebrospinal Fluid Homovanillic and 5-Hydroxyindoleacetic Acids in a Large Pediatric Population; Establishment of Reference Intervals and Impact of Disease and Medication	26
A-343 Novel In-Line Hemolysis Detection on a Blood Gas Analyzer for Capillary Samples	25
Cardiac Troponin I or T for the Diagnosis of Myocardial Infarction and Prediction of Outcomes—Does It Matter?	25
Tumor-Derived HAVCR1 As a Reliable Fluid Biomarker for the Diagnosis of CNS Lymphoma	25
Low Free T4 in a 13-Year-Old Girl with Short Stature and Blurry Vision	25
Third-Generation Single-Molecule Sequencing for Preimplantation Genetic Testing of Aneuploidy and Segmental Imbalances	24
Quantitative Analysis of a Novel Metabolite Panel to Estimate GFR (Panel eGFR) in Serum and Plasma Using LC-MS/MS	24
Correlations Within and Between Highly Multiplexed Proteomic Assays of Human Plasma	23
Establishment of Pseudovirus-Based Reference Materials and Nationwide External Quality Assessment for Arboviruses during the 2025 Chikungunya Outbreak	23
Methods to Improve Confidence in the Accuracy of Molecular Testing for Multidrug-Resistant Tuberculosis	23
Bridging the Gap: Inclusion of Pregnant Women in Clinical Drug Trials	23
A-059 Validation of self-collected capillary dried blood spot collection for clinical HbA1c testing	23
Comprehensive Analysis of PKD1 and PKD2 by Long-Read Sequencing in Autosomal Dominant Polycystic Kidney Disease	22
Lower Limits for Reporting High-Sensitivity Cardiac Troponin Assays and Impact of Analytical Performance on Patient Misclassification	22
Urine Cell-Free RNA vs Plasma Cell-Free RNA for Monitoring of Kidney Injury and Immune Complications	22
A Comprehensive Review of Estradiol, Progesterone, Luteinizing Hormone, and Follicle-Stimulating Hormone in the Context of Laboratory Medicine to Support Women's Health	21
Evolutions in Clinical Chemistry	21
Abatacept as a Mimic of Gamma Heavy Chain Disease	21
New American Society of Hematology Thrombophilia Guidelines Could Provoke Surge in Laboratory Testing	20
“Fireworks” in Fatty Urine	20
Reflecting on 70 Years of Clinical Chemistry	20
A Comment about Analytical Performance Specifications for the Combined Measurement Uncertainty Budget in the Implementation of Metrological Traceability of Parathyroid Hormone	20

A-119 Lipemia Interference	19
A-114 Protective effect of leukocytes in preventing Cold Induced Hyperkalemia	19
B-302 Increased False-Positives vs Increased Interference Flags: Using the AU 5800 to Compare Two Ethyl Glucuronide Assays	19
B-138 A Harmonization Program Leading to Improved Accuracy and Precision of Hemoglobin A1c (HbA1c) Testing: A Six-Year Multi-Site, Multi-Instrument Review and Comparison	19
B-186 Pericentric Inversion of Chromosome 9-inv(9)(p12q13): Findings Beyond Infertility Encountered on a Retrospective Study	19
B-214 Serial Changes of Donor-derived Cell-free DNA in Pancreas Transplant Recipients	19
B-107 Advancing Parasitology Laboratory Quality and Processes Through Artificial Intelligence (AI) and Automation	19
B-089 Development of a Secondary Standard for Quantitation of IgG Antibodies to SARS-CoV-2 Proteins in a Multiplex Assay	19
B-230 Monitoring SARS-CoV-2 Subvariants for Evaluation of the Diagnostic Kit’s Annealing Site Using Nanopore Sequencing	18
A-166 Performance verification of a polyclonal anti-PF4 immunoassay in evaluation of Heparin Induced Thrombocytopenia (HIT)	18
A-002 Analytical Validation of the Zybio High Sensitivity Cardiac Troponin I CLIA Assay	18
B-213 Including Turner Syndrome Screening in Newborn Sequencing by Using NGS Read Counts to Infer Sex Chromosomes Copy Number: Leveraging Existing Data to Enhance Early Diagnosis	18
A-167 Hematologic setpoints are a deep physiologic phenotype which enable personalized blood count reference intervals	17
B-378 Cell-free Plasma Preparation Workflow Solution	17
A-021 Evaluation of a Novel N Terminal Pro B Type Natriuretic Peptide Assay as an aid in the Diagnosis of Acute Heart Failure in the Emergency Department	17
B-141 Surprisingly Good Agreement of Siemens and Roche ALT Reference Change Values in Ottawa Hospital Outpatients Distilled from 5 years and 3 years of Siemens and Roche ALT, Respectively	17
A-086 Clinical Performance of a Plasma ATN Panel for Assessment of Alzheimer’s Disease	17
B-147 Evaluation of Laboratory Database: Is there a Causal Relationship between COVID-19 and Type 1 Diabetes	16
B-086 High Precision T Cell Testing Using the T-SPOT Technology: Improved Cell Yields From Lower Volumes of Blood When the T-SPOT Technology is Used With the T-Cell Select Reagent Kit for Cell Isolati	16
B-071 Unraveling Histamine Intolerance: Exploring DAO Quantity, Elimination Ratios and Cofactor Influences	16
B-010 Comparison of Manual Urine Dipstick and Microscopy With Automated UC-3500 and UF-4000 Sysmex UN Series Urinalysis; A Comparative Experimental Research Approach at an Urban Referral Hospital in G	16
B-329 Comparison Between Trough and AUC Monitoring of MPA in Patients With and Without Organ Transplantation. Influence of the Co-administered Immunosuppressant	16
B-242 Improved Patient Satisfaction With Novel Capillary Blood Collection Devices as an Alternative to Venipuncture for Applications in Clinical Proteomic Assays	16
A-342 Precision Evaluation of the pH, PO2 and PCO2 tests in the i-STAT® G3+ Cartridge using the i-STAT 1 System for Venous, Arterial and Capillary Whole Blood Specimens in	16
B-173 Cystine Analysis in Urine Sample Using the Laser Diode Thermal Desorption technique “LDTD”/Mass Spectrometry (Luxon)	15
B-149 Next-generation Sequencing Via Targeted Metagenomics for Broad Antimicrobial Resistance Surveillance	15
B-214 Mutational Landscapes of Acute Myeloid Leukemia and Myelodysplastic Syndromes: A Database-Driven Comprehensive Myeloid Panel Analysis of DNA Variants and Gene Fusions	15
B-015 Magnesium Fractionation using Ultrafiltration System	15
B-266 Therapeutic Drug Monitoring of Natalizumab and Anti-Natalizumab Antibodies	15
B-222 Receptor-donor CYP3A5 and CYP3A4 genotype testing in liver transplant patients and its influence in tacrolimus blood levels: a retrospective study	15
A-128 Analytical Performance Evaluation of Assays Used for Iron Studies on the Atellica® CI 1900 Analyzer	15
A-010 Clinical Performance of an N-Terminal Pro-B-Type Natriuretic Peptide Assay in Acute Heart Failure Diagnosis	14
We All Know Standardization Is Key, But How Do We Get There with Clinical Metagenomics?	14
Commentary on A Patient with Coarse Facial Features and Molecular Odyssey: Lessons Learned and Best Practice	14
Splicing Predictions, Splicing Assays, and Variant Classification Using ACMG/AMP Guidelines: Challenges Observed with BRCA1 and BR	14
B-321 Development of Chemiluminescent Enzyme Immunoassay (CLEIA) for Detecting Methotrexate in Blood	14
A-302 Agreement Assessment Between Molecular and Rapid Tests in Respiratory Viruses Detection	14
A-155 HbS, HbF and HbA2 reference intervals in a sickle cell population with Senegal haplotype as the most prevalent sickle cell haplotype	14
Enrichment of Microbial DNA in Plasma to Improve Pathogen Detection in Sepsis: A Pilot Study	14
B-301 In-vivo Continuous Therapeutic Drug Monitoring With Electrochemical Aptamer-based Sensors	14
A-180 A Retrospective Review of Syphilis Serology Interpretation Accuracy	14
A-191 Evaluating the Impact of Drone Delivery on Blood Sample Quality: A Multi-faceted Validation Approach	13
B-079 Analytical comparison of a novel, fully automated multiplexed microarray immunoassay and routine methods for the detection of celiac disease autoantibodies in a reference laboratory in Wales	13
A-080 Clinical Significance of Magnesium in Patients Undergoing Renal Dialysis	13
A-180 Counting CAP deficiency Caused by Clerical errors: a regional study	13
B-114 Analytical characterization of a host-response test able to rapidly differentiate bacterial from viral infections developed for use on Beckman Coulter immunoassay analyzers	13
A-227 Breaking Barriers in Laboratory Efficiency: A PDCA-Driven Approach to Fasting Emergency Testing	13
A-275 Evaluation of Dried Blood Spots for Serological Detection of Chagas Disease	13
A-133 iSED PRO: Utilizing Photometric Rheology to Modernize High Throughput Erythrocyte Sedimentation Rate Testing	13
B-006 Locus Coeruleus Activation Causes Dynorphin Release in Mouse Brain: Implications for Neural Inflammation	12
B-198 Comparative Analysis of Inductively Coupled Plasma-Mass Spectrometry (ICP-MS) with Kinetic Energy Discrimination Mode Using Helium and ICP-MS/MS with Collision/Reaction Cell Mode Using Oxygen fo	12
B-036 Paving the path for autonomous mobile robots (AMRs) in the clinical laboratory: A pilot study of Collaborative Robotics (Cobot) Proxie robot for cart movement at Mayo Clinic Laboratories	12
B-182 Development and validation of an LC-MS/MS assay for simultaneous measurement of serum androstenedione and 17-hydroxyprogesterone in serum	12
The Unique Utility of Newborn Dried Blood Spots for Driving Discovery in Childhood Cancer Research	12
B-367 Correlation of kappa and lambda free light chain results between Siemens N Latex assays on BN II analyzer and Binding Site Freelite assays on Optilite platform	12
B-062 Impact of prolonged air exposure on stability of Carbon Dioxide (CO2), Chloride (Cl), Potassium (K) and Sodium (Na) assessed by Roche Cobas® c702 Analyzer	12
B-293 Comparison of Therapeutic Drug Monitoring for Clozapine by Immunoassay vs. Mass-Spectrometry	12
Ceramide Risk Scores Can Bring Lipidomics to Clinical Medicine	12
Establishing Pragmatic Analytical Performance Specifications for Blood Beta-Hydroxybutyrate Testing	12
B-206 The Determination of Vanillylmandelic Acid (VMA), Homovanillic Acid (HVA) and 5-Hydroxyindolacetic Acid (5-HIAA) by LC-Ms/MS Assay in Urine Samples for Diagnosis of Neuroendocrynes Tumors	12
B-069 An Effort on Improvement of the Anti M-Protein Interference to Enzymatic Creatinine Assay on Mindray BS-2800M System	12
B-193 Establishing a robust liquid chromatography-tandem mass spectrometry method for urinary steroid profiling with efficient enzymatic pretreatment	12
A-052 Clinical usefulness of ADAMS A1c HA-8190V automatic switching mode for the HbA1c measurement in Hb variants	12
A-038 Interlaboratory Comparison of Parathyroid Hormone Analytical Results Across Clinical Assays from 8 Manufacturers - Steps Towards Standardization	12
Deconvolution of BNP and NT-proBNP Immunoreactivities by Mass Spectrometry in Heart Failure and Sacubitril/Valsartan Treatment	12
Worldwide Increasing Use of Nonfasting Rather Than Fasting Lipid Profiles	11
Long-Term Within- and Between-Subject Biological Variation Data of Hematological Parameters in Recreational Endurance Athletes	11
Expanding Access to Noninvasive Prenatal Diagnosis for Monogenic Conditions to Consanguineous Families	11
A Modified Sampson–NIH Equation with Improved Accuracy for Estimating Low Levels of Low-Density Lipoprotein-Cholesterol	11
UMIErrorCorrect and UMIAnalyzer: Software for Consensus Read Generation, Error Correction, and Visualization Using Unique Molecular Identifiers	11
A New Concept for Reference Change Values—Regression to the Population Mean	11
Assessing the Quality of Metagenomic Next-Generation Sequencing for Pathogen Detection in Lower Respiratory Infections	11
Low-Pass Whole Genome Sequencing of Cell-Free DNA from Cerebrospinal Fluid: A Focus on Pediatric Central Nervous System Tumors	11
Establishing Reference Values in Healthy Participants for the Cardiac Troponin T High-Sensitivity Gen 6 Assay: REF-TSIX Global Reference Study	11
Prognostic Value of Cardiac Myosin Binding Protein C in the General Population: The Akershus Cardiac Examination 1950 Study	11
A-297 Usefulness of Non-Skin Samples in the PCR Diagnosis of Monkeypox	11
B-308 Analytical and clinical performance of a novel ovarian cancer screening test in asymptomatic women	10
A-346 Evaluating 14-3-3η Detection in Finger Prick Blood Using Lateral Flow Technology: Advancing Clinical Laboratory Diagnostics	10
B-056 Performance Characteristics of a New, Fully Automated Planar Microarray Immunoassay for the Detection of IgG Auto-Antibodies Against Centromere Protein B (CENP-B)	10
A-156 White Blood Cell Measurands, Flagging and Scatter Plot Patterns in Chronic Lymphocytic Leukemia	10

A-322 Implementation of Three Age- and Sex-Dependent Equations to Estimate Glomerular Filtration Rates (eGFR) at a Pediatric Institution	10
A-073 Is there a relationship of FIB 4 with weight and insulin resistance in subjects without type 2 diabetes and with normal transaminases?	10
A-228 Performance Evaluation of the LabGenius C-CT/NG-BMX Assay for Detection of Chlamydia trachomatis and Neisseria gonorrhoeae	10
B-098 Clinical comparison of five assays for the detection of anti-dsdna antibodies and their correlation with complement consumption	10
B-220 Clinical Application of the “Clg-Fish” Technique for the Diagnosis of Multiple Myeloma	10
A-219 A Multiplexed Targeted Assay for Gangliosides Using Liquid Chromatography-Tandem Mass Spectrometry	10
B-181 Multi-centre Analytical Performance Evaluation of the EXENTâ Solution for Identification and Quantitation of Monoclonal Immunoglobulins	10
A-389 Implementation of a solicited laboratory workflow improves quality indicators for point of care blood gas testing by Respiratory Therapists	10
B-233 Chromatin Accessibility Uncovers KRAS-driven FOSL2 Promoting Pancreatic Ductal Adenocarcinoma Progression Via Upregulating CCL28	10
A-191 Improvement of Outpatient Satisfaction Rate at Specimen Collection Area	10
A-049 Inter-assay Variation of Insulin-like Growth Factor-1 Remains an Issue	10
A-009 Analytical Characterization of a Novel NT-proBNP Assay on a Central Laboratory Platform	10
More Than a Decade of Rapid Genomic Sequencing: Where Are We Now?	9
B-208 Correlation Studies of Human Papillomavirus DNA on Roche Cobas vs Human Papillomavirus mRNA on Hologic Panther	9
Interlaboratory Comparison of Antibody-Free LC-MS/MS Measurements of C-peptide and Insulin	9
A-054 Comparison of a Reformulated Vitamin D Immunoassay, Its Predecessor, and Two Contemporary Formulations	9
Commentary on An Unusual Presentation of Autoimmune Primary Adrenal Insufficiency	9
A-353 Lay User testing of Rapid Multiplexed HIV/TP test	9
Challenges in Hb A1c Point-of-Care Testing: Only 5 of 19 Hb A1c Point-of-Care Devices Meet IFCC and NGSP Certification Criteria on Independent Evaluation	9
A-233 Novel Microfluidic System for Antimicrobial Susceptibility Testing	9
B-278 Pilot Clinical Study of the CarePoint Assay	9
Multiple Cardiac Biomarkers to Improve Prediction of Cardiovascular Events: Findings from the Generation Scotland Scottish Family Health Study	9
A-258 Hepatitis A infections among patients suspected of acute hepatitis attended in Brazilian health services	9
Commentary on Mosaic Copy Number Variation in a Patient with Cerebral and Pulmonary Arteriovenous Malformations and Recurrent Epistaxis	9
A-198 Reducing Specimen Rejections in Ambulatory Care Clinics to Improve Patient Safety and Efficiency	8
B-044 A Statistical and Rule-Based Approach to Automating Glioblastoma Detection	8
A-129 ANALYTICAL VALIDATION OF THE NEXT-GENERATION T-TAS wS SYSTEM	8
A-211 A real-world retrospective multi-hospital database evaluation of the clinical care gaps associated with urine contamination/ false positive cultures and associated outcomes in the United States	8
A-259 Urine Gene Analysis Compared to Urine Culture For Pathogen Detection	8
A-348 Pediatric reference intervals for 12 enzymes, proteins, and lipids on the Roche cobas® pro Integrated System established using the CALIPER cohort of healthy children	8
A-322 ELISA-based determination of anti-mumps IgG reveals a prevalence of 80 percent in sera obtained in Brazil	8
B-168 Establishment of reference intervals of serum immunoglobulin and complement by Hoffmann and refineR algorithms and evaluation of their feasibility	8
A-056 Ex-Vivo Parathyroid Aspiration in Parathyroidectomy: Correlation with Histopathology and Biochemical Outcomes in Single- and Multi-glandular Primary Hyperparathyroidism	8
A-162 Prevalence of EDTA-Dependent Pseudothrombocytopenia: A 10-Year Analysis	8
In Reply to Beyond the Screen Positive Rate: Racial Equity Considerations for Serum Screening for Open Neural Tube Defects	8
A-410 A laser scanning smartphone-based imaging platform toward point-of-care diagnostic testing	8
A-205 Abbott Alinity i Analyzers: More Than Just Hot Air!	8
B-292 Performance of fentanyl immunoassays in a pediatric patient population	7
B-078 Validation of the GCAL®, Gentian Calprotectin Immunoassay on the QuidelOrtho Vitros 5600 Chemistry Analyzer	7
A-282 Detection of anti-Oropouche virus-specific IgM in a patient panel from a Zika virus epidemic area in 2015 / 2016	7
Reference Interval Harmonization: Will Big Data Provide a Solution?	7
A-347 Statistical determination of infant (<6 months) PT and PTT reference intervals	7
B-234 Detection of multiple targets in a single fluorescent channel: Respiratory virus multiplex RT-qPCR assay	7
Do You See What I See? Automated IFE Interpretation Using Machine Learning	7
Extent of Equivalence of Results for Urine Albumin among 3 Candidate Mass Spectrometry Reference Measurement Procedures	7
ADOPT Automated Phlebotomy: Exceptional Performance. Unproven Generalizability across Skin Tones	7
Detection of Clinically Relevant Monogenic Copy-Number Variants by a Comprehensive Genome-Wide Microarray with Exonic Coverage	7
Patient with a New Small IgG Kappa Monoclonal Protein	7
A-378 Acceptance and Harmonization of i-STAT Cartridges. A Practical Example with G3+ cartridges	7
B-247 BLADE-R: streamlined RNA extraction for clinical diagnostics and high-throughput applications	7
Transitioning Alzheimer Disease Blood Biomarkers into Primary Care: Are We There Yet?	7
Next-Level Natriuretic Peptide Measurement	7
B-054 Performance Evaluation of the VITROS HIV Combo Assay on the Ortho VITROS 3600 system	7
A-400 11 month study of thrice daily testing of blood samples on dual GEM 5000s demonstrates 24 hour new cartridge instability	7
A-299 The Clinical Triaging Impact of New HPV Platforms. A Comparison of mRNA and DNA Based Platforms	7
Commentary on Severe Hypophosphatemia: The Hidden Truth	6
Commentary on Positive Syphilis Serologies after Intravenous Immunoglobulin Treatment: A Diagnostic Confusion That Needs Emphasis	6
Age-Specific Control and Alzheimer Disease Reference Curves and z -Scores for Glial Fibrillary Acidic Protein in Blood	6
Commentary on Negative Sweat Chloride Testing in the Setting of a Positive Newborn Screen and CFTR Compound Heterozygosity	6
Pediatric Vaccine-Induced Antibody Thresholds: Rethinking Pre-Immunosuppression Serologic Testing and Revaccination Implications	6
A-153 Study of the evaluation of fragment flag and percentage schistocyte count in MINDRAY® BC-6800 PLUS in a public pediatric hospital in Argentina	6
Next-Generation Methods for More Precise Measurement of Cancer Genetic Changes	6
B-212 Laboratory Performance in Molecular Detection of Mycobacterium tuberculosis Through Analysis of External Quality Assessment Program Results: WHO-Recommended Tests Outperform Others	6
A-004 Analytical Assessment and Expanded Stability Studies of the Abbott Alinity i STAT High Sensitivity Troponin-I Assay	6
Government Mandates Immediate Access to Cancer Test Results: Patient Empowerment or Secondary Harm?	6
Autoverified Chocolate-Colored Plasma Samples	6
Keeping It under Control: Developing Reference Materials during a Rapidly Evolving Arboviral Outbreak	6
Editor's Note: Circulating Proteolytic Products of Carboxypeptidase N for Early Detection of Breast Cancer	6
A-362 Hemolysis Detection and Flagging of Potassium Results on GEM Premier 7000 with iQM3	6
B-165 The EXENT System reliably distinguishes daratumumab from endogenous monoclonal immunoglobulins in multiple myeloma patients	6
B-248 Enhanced Detection of of Hemoglobin Variants in Clinical Research using Dried Blood Spot and HRAM MS	6
A-262 Analytical and Clinical Validation of a Multiplex RT-PCR based Mpox Assay	6
The Pivotal Role of Whole Genome and Transcriptome Sequencing in a Rare Case of Systemic Mastocytosis with Associated Myelodysplastic/Myeloproliferative Neoplasm with Neutrophilia	6
Placental Biomarker Testing for Evaluation of Suspected Preeclampsia	6
Personalized and Population-Based Reference Intervals for 48 Common Clinical Chemistry and Hematology Measurands: A Comparative Study	6
Determinants of Cardiac Myosin Binding Protein C in the General Population	6
B-184 Development and Validation of a High-performance Liquid Chromatography-Mass Spectrometry Method for Analyzing Phenolic Acids Metabolites in Feces	6
B-303 Comparison of Tacrolimus Concentrations Obtained By the Newly Approved Alinity i Tacrolimus Assay With a Reference Liquid-Chromatography Combined With Tandem Mass spectrometry Assay	6
A-327 Pre-analytical and Analytical Modifications to Improve the Quality of Pediatric Lead Tests	6
B-336 Comparison of the LZI Fentanyl Enzyme Immunoassay With ARKII and SEFRIA Fentanyl Assays on Beckman AU Analyzer	6
Perinatal Diagnostics and Risk Prediction: Current Practice and Future Directions	5
A-361 Long-term analytical variation of placental growth factor (PlGF) and soluble fms-like tyrosine kinase-1 (sFlt-1) for preeclampsia risk assessment: a 5-year review	5
A-175 Distribution of ADAMTS13 Inhibitor Levels as a Function of ADAMTS13 Activity	5
A-315 Synthesis and biological evaluation of orally active anti-Trypanosoma agents	5
A-245 Development and validation of fatty acid analysis in whole blood by GC-FID	5
B-177 Quantitative Measurement of Vitamin B1 in Whole Blood using a Multiplex ESI-LC-MS/MS System	5
A-358 Comparison of Immunoregulatory miRNA, Human Milk oligosaccharides (HMO’s) and Gut Microbiomes between Infants Fed with Human Breast Milk Versus Infant Formula	5
A-377 Lyophilized Respiratory Viruses: A Streamlined Approach to Accessible Precision Quality Control Testing for the Point of Care Environment	5
A-145 Evaluating clinician compliance with laboratory guidance for prolonged aPTT testing	5
A-326 Evaluation of a Hepatitis B Core Total Antibody Assay Eliminating the Retest Zone and Its Post-Live Performance	5
B-099 Development and Improvement of Novel MASTM Infectious Controls for Serology Diagnostic Tests	5
Six-Color Multiplex Digital PCR Assays for Comprehensive Screening and Identification of Multiple Driver Mutations Associated with Pancreatic Carcinogenesis	5
A-380 Maverick: Revolutionizing Immunoassay Testing with Photonic Ring Resonance Technology for Faster, More Accurate Results	5
Unmet Clinical Needs and Remaining Challenges of Pregnancy Reference Intervals	5
A-144 Is the Q Flag (Blast/Abn Lympho) a sensitive tool for detecting a hematological neoplasm?	5